• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

OptiNose

OptiNose IPO pulls in $120m

October 16, 2017 By Brad Perriello

Optinose Xhance

OptiNose (NSDQ:OPTN) raised $120 million with its initial public offering last week, adding $20 million to the target is set earlier this month. Yardley, Penn.-based OptiNose floated 7.5 million shares at $16 apiece in the offering, above the range it set Oct. 3 for 6.3 million shares at $15 to $17 apiece. The stock, trading on the […]

Filed Under: Featured, Funding Roundup, Initial Public Offering (IPO), Otolaryngology Ear, Nose & Throat, Wall Street Beat Tagged With: OptiNose

OptiNose sets terms for $100m IPO

October 5, 2017 By Sarah Faulkner

Optinose Xhance

OptiNose set terms for its IPO this week, according to a regulatory filing submitted to the SEC. The company plans to offer 6.3 million shares at $15 – $17 apiece and funds affiliated with Avista Capital Partners intend to buy $25 million worth of shares as part of the offering, according to OptiNose. The company […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Initial Public Offering (IPO), Otolaryngology Ear, Nose & Throat, Wall Street Beat Tagged With: OptiNose

OptiNose registers $100m IPO

September 20, 2017 By Sarah Faulkner

Optinose Xhance

OptiNose has registered a $100 million initial public offering with the SEC to list its common stock on the Nasdaq market, according to a regulatory filing. The Yardley, Penn.-based company posted a net loss of -$16.3 million in the six months ended June 30, 2017 – down from a $34.3 million net profit during the […]

Filed Under: Drug-Device Combinations, Featured, Initial Public Offering (IPO), Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: OptiNose

OptiNose wins FDA nod for Xhance nasal spray

September 19, 2017 By Sarah Faulkner

Optinose Xhance

OptiNose said today that the FDA approved its Xhance nasal spray for the treatment of nasal polyps in patients 18 years and older. The fluticasone propionate nasal spray is designed to deliver medication using OptiNose’s exhalation delivery system. The patient actuates the pump spray into one nostril while simultaneously blowing into the mouthpiece of the […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Regulatory/Compliance Tagged With: OptiNose

OptiNose raises $37m in Series D for commercial efforts

May 9, 2017 By Sarah Faulkner

OptiNose

OptiNose said today that it closed a $37 million Series D round led by Fidelity Management and Research Company. Avista Capital Partners, Entrepreneurs Fund and other current investors also contributed to the round. The Yardley, Penn.-based company said it plans to use the newly-acquired funds to support commercial development of its lead product candidate, OPN-375, […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Respiratory Tagged With: OptiNose

OptiNose touts Phase III data for exhaled breath drug delivery

September 16, 2016 By Sarah Faulkner

OptiNose

OptiNose touted data from a pair of Phase III clinical trials proving the safety and efficacy of its exhaled breath drug delivery treatment for chronic rhinosinusitis patients with and without polyps. The company presented the data today at the American Rhinologic Society’s annual meeting in San Diego. Data from both trials showed limited adverse effects from […]

Filed Under: Clinical Trials, Drug-Device Combinations, Respiratory Tagged With: OptiNose

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS